RxSight, Inc., headquartered in Aliso Viejo, California, is a medical technology company focused on improving visual outcomes following cataract surgery. With a growing international presence, RxSight is expanding access to its technology across global markets, including Australia.

The company has developed the Light Adjustable Lens™ (LAL®), the first and only intraocular lens designed to be adjusted after implantation. Made from a proprietary photosensitive material, the lens can be modified postoperatively through controlled UV light treatments delivered in-office.

This approach enables surgeons to refine refractive outcomes following surgery based on each patient’s healing response, offering an additional level of precision beyond the operating room.

RxSight is committed to advancing cataract surgery through innovation, clinical education, and collaboration with eye care professionals worldwide.